Prospective studies are thus needed to evaluate the usefulness of blood NfL in the diagnostic work-up for dementia, similar to the evaluation studies that were performed for the classical AD biomarkers in cerebrospinal fluid (CSF) [20, 21]. The gene discussed is NEFL; the disease is Alzheimer disease.